Valuation: Aprogen Biologics Inc.

Market Cap 2.24TCr 1.69Cr 1.52Cr 1.4Cr 1.27Cr 2.38Cr 160.71Cr 2.41Cr 17Cr 6.68Cr 84Cr 6.35Cr 6.22Cr 267.13Cr P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 20TCr 15Cr 14Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 149.48Cr 59Cr 749.06Cr 56Cr 55Cr 2.38TCr EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
24.16%
Yield 2024 *
-
Yield 2025 -
1 day+0.58%
1 week-7.41%
Current month-5.65%
1 month-15.38%
3 months-33.48%
6 months-63.16%
Current year-82.18%
1 week 1,369
Extreme 1369
1,509
1 month 1,369
Extreme 1369
1,725
Current year 1,369
Extreme 1369
8,490
1 year 1,369
Extreme 1369
9,945
3 years 1,369
Extreme 1369
53,250
5 years 1,369
Extreme 1369
1,54,500
10 years 1,369
Extreme 1369
8,58,000
Manager TitleAgeSince
Chief Executive Officer 63 13/10/2023
Chief Executive Officer 70 01/04/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 01/04/2012
Director/Board Member 65 23/03/2020
Director/Board Member 63 13/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/06/24 Exercice 3,282 0.0025% -
28/06/24 Exercice

Executive/Senior Manager

6,183 0.0046%
28/06/24 Expiration

Chief Executive Officer

21,884 0.0164%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%-7.41%-83.55%-97.19% 1.68Cr
+0.22%+3.35%+55.30%+125.65% 1,14000Cr
+0.91%+5.89%+41.14%+80.36% 64TCr
-0.12%+1.31%+25.62%+97.24% 51TCr
+0.63%+4.97%+47.12%+68.18% 38TCr
+0.86%-1.26%+62.10%+34.36% 35TCr
+1.02%+3.69%+23.73%+51.35% 29TCr
-0.25%+3.40%+2.31%+23.38% 27TCr
+0.75%+5.41%+53.53%+66.09% 24TCr
+0.25%+3.93%+31.54%+102.65% 20TCr
Average +0.52%+2.26%+25.88%+55.21% 40.14TCr
Weighted average by Cap. +0.55%+2.98%+42.01%+84.56%

Financials

2024 2025
Net sales 6.74TCr 5.08Cr 4.56Cr 4.21Cr 3.82Cr 7.13Cr 482.38Cr 7.22Cr 50Cr 20Cr 252.84Cr 19Cr 19Cr 801.8Cr 7.32TCr 5.52Cr 4.95Cr 4.57Cr 4.15Cr 7.75Cr 524.24Cr 7.85Cr 55Cr 22Cr 274.79Cr 21Cr 20Cr 871.39Cr
Net income -10TCr -7.91Cr -7.1Cr -6.56Cr -5.95Cr -11Cr -751.57Cr -11Cr -79Cr -31Cr -393.94Cr -30Cr -29Cr -1.25TCr -17TCr -13Cr -12Cr -11Cr -9.65Cr -18Cr -1.22TCr -18Cr -127.56Cr -51Cr -639.18Cr -48Cr -47Cr -2.03TCr
Net Debt 12TCr 8.72Cr 7.83Cr 7.23Cr 6.55Cr 12Cr 828.31Cr 12Cr 87Cr 34Cr 434.17Cr 33Cr 32Cr 1.38TCr 18TCr 13Cr 12Cr 11Cr 10Cr 19Cr 1.27TCr 19Cr 132.67Cr 53Cr 664.82Cr 50Cr 49Cr 2.11TCr
Projected Income Statement - Annual - Aprogen Biologics Inc.
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
27/26/27 ₩1,387.00 +0.58% 47,488
26/26/26 ₩1,379.00 -0.58% 98,417
23/26/23 ₩1,387.00 -1.49% 1,07,052
22/26/22 ₩1,408.00 -2.22% 1,15,788
21/26/21 ₩1,440.00 -1.50% 84,857
  1. Stock Market
  2. Stocks
  3. A003060 Stock